Muvalaplin

Muvalaplin is a small molecule drug. Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events). Muvalaplin has a monoisotopic molecular weight of 710.4 Da. Other names for this substance include Muvalaplina and Muvalapline. Its PubChem CID is 155369486.

CAS No 2565656-70-2
Molecular Formula C42H54N4O6
Molecular Weight 710.9 g/mol
Synonyms (2S)-3-[3-[[bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3R)-pyrrolidin-3-yl]propanoic acid

Frequently Asked Questions